177 related articles for article (PubMed ID: 18322167)
1. Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences.
Golden-Mason L; Klarquist J; Wahed AS; Rosen HR
J Immunol; 2008 Mar; 180(6):3637-41. PubMed ID: 18322167
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
[TBL] [Abstract][Full Text] [Related]
3. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
Rutebemberwa A; Ray SC; Astemborski J; Levine J; Liu L; Dowd KA; Clute S; Wang C; Korman A; Sette A; Sidney J; Pardoll DM; Cox AL
J Immunol; 2008 Dec; 181(12):8215-25. PubMed ID: 19050238
[TBL] [Abstract][Full Text] [Related]
4. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
[TBL] [Abstract][Full Text] [Related]
5. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.
McMahan RH; Golden-Mason L; Nishimura MI; McMahon BJ; Kemper M; Allen TM; Gretch DR; Rosen HR
J Clin Invest; 2010 Dec; 120(12):4546-57. PubMed ID: 21084749
[TBL] [Abstract][Full Text] [Related]
6. PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients.
Shen T; Zheng J; Xu C; Liu J; Zhang W; Lu F; Zhuang H
Virol J; 2010 Nov; 7():310. PubMed ID: 21070674
[TBL] [Abstract][Full Text] [Related]
7. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
[TBL] [Abstract][Full Text] [Related]
8. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
[TBL] [Abstract][Full Text] [Related]
9. Identification of IL-10-secreting CD8
Wang W; Tong Z; Zhong J; Zhang L; Zhang H; Su Y; Gao B; Zhang C
Immunol Lett; 2018 Oct; 202():16-22. PubMed ID: 30055200
[TBL] [Abstract][Full Text] [Related]
10. Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults.
Duraiswamy J; Ibegbu CC; Masopust D; Miller JD; Araki K; Doho GH; Tata P; Gupta S; Zilliox MJ; Nakaya HI; Pulendran B; Haining WN; Freeman GJ; Ahmed R
J Immunol; 2011 Apr; 186(7):4200-12. PubMed ID: 21383243
[TBL] [Abstract][Full Text] [Related]
11. [Alteration of CD100 expression on natural killer cells in chronic patients with hepatitis C virus before and after initiation of antiviral treatment].
He Y; Li B; Zhou Y; Zhang Y; Guo Y; Ji G; Fan C; Jia Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):856-60. PubMed ID: 25108441
[TBL] [Abstract][Full Text] [Related]
12. [Dynamic changes in programmed death-1 expression on the surface of T cells in chronic hepatitis C patients undergoing interferon therapy].
Dong RQ; Zhou DF; Han R; Zhou JY; Zhao CY; Zhen Z
Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):899-902. PubMed ID: 24636290
[TBL] [Abstract][Full Text] [Related]
13. Peripheral PD-1
Romani S; Stafford K; Nelson A; Bagchi S; Kottilil S; Poonia B
Front Immunol; 2019; 10():1470. PubMed ID: 31316516
[TBL] [Abstract][Full Text] [Related]
14. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
[TBL] [Abstract][Full Text] [Related]
15. PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.
Xiao W; Jiang LF; Deng XZ; Zhu DY; Pei JP; Xu ML; Li BJ; Wang CJ; Zhang JH; Zhang Q; Zhou ZX; Ding WL; Xu XD; Yue M
Immunol Res; 2016 Apr; 64(2):412-23. PubMed ID: 26286967
[TBL] [Abstract][Full Text] [Related]
16. Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses.
Pillai V; Lee WM; Thiele DL; Karandikar NJ
J Viral Hepat; 2007 May; 14(5):318-29. PubMed ID: 17439521
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients.
Shen T; Zheng J; Liang H; Xu C; Chen X; Zhang T; Xu Q; Lu F
Virol J; 2011 Jun; 8():279. PubMed ID: 21645420
[TBL] [Abstract][Full Text] [Related]
18. Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment.
Bozzano F; Picciotto A; Costa P; Marras F; Fazio V; Hirsch I; Olive D; Moretta L; De Maria A
Eur J Immunol; 2011 Oct; 41(10):2905-14. PubMed ID: 21695691
[TBL] [Abstract][Full Text] [Related]
19. Equally poor outcomes to pegylated interferon-based therapy in African Americans and Hispanics with chronic hepatitis C infection.
Satapathy SK; Lingisetty CS; Proper S; Chaudhari S; Williams S
J Clin Gastroenterol; 2010 Feb; 44(2):140-5. PubMed ID: 19826275
[TBL] [Abstract][Full Text] [Related]
20. Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.
Hoofnagle JH; Wahed AS; Brown RS; Howell CD; Belle SH;
J Infect Dis; 2009 Apr; 199(8):1112-20. PubMed ID: 19284286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
